This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.
A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
| Facility | City | Region | Status |
|---|---|---|---|
| University of Missouri Health Care | Columbia | Missouri | Recruiting |
| Jersey City Medical Center RWJ Barnabas Health | Jersey City | New Jersey | Recruiting |
| Saint Barnabas Medical Center Livingston | Livingston | New Jersey | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | Recruiting |
| Universitaire Ziekenhuiven Leuven | Leuven | Belgium | Recruiting |
| Hospital Santa Clara | Bogotá | Colombia | Recruiting |
| Charité Universitätsmedizin Berlin | Berlin | Germany | Recruiting |
| BG-Unfallklinik Ludwigshafen | Ludwigshafen | Germany | Recruiting |
| Universitätsklinikum Münster | Münster | Germany | Recruiting |
| Hospital Universitario Son Llàtzer | Palma de Mallorca | Spain | Recruiting |
| Universitätsspital Basel | Basel | Switzerland | Recruiting |
| Kantonspital Baselland | Liestal | Switzerland | Terminated |
| Universitätsspital Zürich | Zurich | Switzerland | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03378557 on ClinicalTrials.gov ↗ ← All trials in Germany